MIRD pamphlet no. 14 revised: A dynamic urinary bladder model for radiation dose calculations

Journal of Nuclear Medicine

Volumn 40, Issue 4, 1999, Pages

  Thomas, Stephen R ^a   Stabin, Michael G ^c   Chen, Chin Tu ^c   Samaratunga, Ranasinghage C ^c   Watson, Evelyn E ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MIRD Committee   (United States)

^c NONE

Author keywords

Dosimetry; Dynamic bladder; MIRD dose calculation; Urinary bladder radiation absorbed dose

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

ARTICLE; BLADDER; CLINICAL PROTOCOL; DOSIMETRY; MICTURITION; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032937790     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thomas SR, Stabin MG, Chen C-T, Samaratunga RC. MIRD Pamphlet No. 14: a Dynamic Urinary Bladder Model for Radiation Dose, Calculations. J Nucl Med 1992;33:783-802.
2. [Erratum]. J Nucl Med 1994;35:73.
3. 18F]fluoro-2-deoxy-D-glucose in adult humans. J Nucl Med 1991;32:707-712.
4. Chen C-T, Harper PV, Lathrop KA. A simple dynamic model for calculating radiation absorbed dose to the bladder wall. In: Schlafke-Stelson AT, Watson EE, eds. Fourth International Radiopharmaceutical Dosimetry Symposium, Nov. 5-8, 1985, Oak Ridge, TN: CONF-851113-(DE86010102), 587-612.
5. Snyder WS, Ford MR, Warner GG. MIRD Pamphlet No. 5 (Revised): estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of heterogeneous phantom. New York: The Society of Nuclear Medicine: 1978.
6. Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. I. Methods, ORNL Publ. No. TM-8381/V1. 1987.
7. Cloutier RJ, Smith SA, Watson EE. et al. Dose to the fetus from radionuclides in the bladder. Health Phys 1973;25:147-161.
8. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York: The Society of Nuclear Medicine; 1988.
9. Snyder WS, Ford MR, Warner GG, Watson SB. MIRD Pamphlet No. 11: "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. New York: The Society of Nuclear Medicine: 1975.
10. Snyder WS, Ford MR, Warner GG, Watson SB. A tabulation of dose equivalent per microcurieday for source and target organs of an adult for various radionuclides. ORNL 5000. Oak Ridge TN: Oak Ridge National Laboratory; 1975.
11. Loevinger R, Japha EM, Brownell GL. Discrete radioisotope sources. In: Hine GJ, Brownell GL, eds. Radiation dosimetry. New York: Academic Press; 1956:693-799.
12. Snyder WS, Ford MR. Estimation of dose to the urinary bladder and to the gonads. In: Cloutier RJ, Coffey JL, Snyder WS, Watson EE, eds. Radiopharmaceutical dosimetry symposium, HEW Publication (FDA) 76-8044, 1976. Oak Ridge, TN, April 26-29, 1976. 313-350.
13. Berger MJ. MIRD Pamphlet No. 7: distribution of absorbed dose around point sources of electrons and beta particles in water and other media. J Nucl Med 1971;12(supp 5).
14. Berger MJ. Beta-ray dosimetry calculations with the use of point kernels in medical radionuclides, radiation dose and effects. AEC Symposium Series No. 20. USAEC Division of Technical Information, 1970.
15. Smith EM, Warner GG. Practical methods of dose reduction to the bladder wall. In: Radiopharmaceutical dosimetry symposium. Oak Ridge, TN, April 26-29, 1976, 351-359.
16. 99mTc-DTPA [Letter]. Br J Radiol 1976;49:196-198.
17. Powell GR, Chen C-T. Radiation absorbed dose to bladder walls from positron emitters in the bladder content. Med Phys 1987;14:1079-1086.
18. Bochkarev VV, Radzievsky GB, Timofeev LV, Demiano DA. Distribution and absorbed energy from a point beta-source in a tissue equivalent medium. Int J Appl Radiat Isot 1972;23:493.
19. Unnikrishnan K. Dose to the urinary bladder from radionuclides in urine. Phys Med Biol 1974;19:329-340.
20. Dimitriou P, Fretzayas A, Nicolaidou P, et al. Estimates of dose to the bladder during direct radionuclide cystography: concise communication. J Nucl Med 1984;25:792-795.
21. Smith T, Veall N, Wotton R. Bladder wall dose from administered radiopharmaceuticals: the effects of variations in urine flow rate, voiding interval, and initial bladder content. Radiat Prot Dosim 1982;2:183-189.
22. Jones S, Alavi A, Christman D, Montanez I, Wolf A, Reivich M. The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med 1982;23:613-617.
23. Thomas SR, Atkins HL, McAfee JG, et al. MIRD Dose Estimate Report No. 12: radiation absorbed dose from Tc-99m diethylenetriaminepentaacetic acid (DTPA). J Nucl Med 1984;25:503-505.
24. Lathrop KA, Atkins HL, Berman M, et al. Summary of current radiation dose estimates to normal humans from Tc-99m as sodium pertechnetate. J Nucl Med 1976;17:74-77.
25. Weber DA, Makler PT Jr, Watson EE, et al. Radiation absorbed dose from technetium-99-labeled bone imaging agents. J Nucl Med 1989;30:1117-1122.
26. Soundy RG, Tyrell DA, Pickett RD, Stabin MG. The radiation dosimetry of Tc-99m exametazime. Nucl Med Commun 1990;11:791-799.
27. Radiation dose to patients from radiopharmaceuticals (technetium-gluconate, glucoheptonate). In: ICRP Publication No. 53. a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press. Inc.; 1988:193-194.
28. Radiation dose to patients from radiopharmaceuticals (technetium-labelled albumin (HSA)). In: ICRP Publication No. 53: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press, Inc.; 1988:173.
29. Radiation dose to patients from radiopharmaceuticals (technetium-labelled erythrocytes). In: ICRP Publication No. 53: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press, Inc.; 1988:209-210.
30. Radiation dose to patients from radiopharmaceuticals (technetium-labelled MIBI). In: ICRP Publication No. 62: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Tarrytown, NY: Pergamon Press, Inc.; 1993: 21-24.
31. Berman M, Braverman LE, Burke J, et al. Summary of current radiation dose estimates to humans from I-123, I-124, I-125, I-126, I-130, I-131, and I-132 as sodium iodide. J Nucl Med 1975;16:857-860.
32. 131I-hippuran renography. Med Phys 1974;1:193-197.
33. Radiation dose to patients from radiopharmaceuticals (iothalamate). In: ICRP Publication No. 53: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press, Inc.; 1988:315-316.
34. Radiation dose to patients from radiopharmaceuticals (indium-DTPA). In: ICRP Publication No. 53: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press, Inc.; 1988:237-240.
35. Radiation dose to patients form radiopharmaceuticals (strontium). In: ICRP Publication No. 53: a report of Task Group of Committee 2 of the International Commission on Radiation Protection. Elmsford, NY: Pergamon Press, Inc.; 1988:169-171.
36. Weber DA, Eckerman KF, Dillman LT, et al. MIRD: radionuclide data and decay schemes. New York: The Society of Nuclear Medicine; 1989.